Healthtech Startups

bekome offers an anxiety-relief program combining expert coaching, personalized nutrition plans, and clinician-supported nutrient supplements aimed at addressing the root causes of anxiousness. It serves individuals seeking side-effect-free mental wellbeing support through the gut-brain connection.

2 investors

Belong Health provides a full-stack health plan operating platform and partnership model that helps organizations design and run health plans, sharing the risk of launching and building them. It focuses on patient engagement using behavioral science to improve care and reduce cost for underserved and complex populations, particularly Medicare and Medicaid-type members.

2 investors

Benchify converts healthcare payer and provider contracts into executable logic to predict claim denials, verify payments, and identify underpayments against contract terms. The platform serves hospitals, health systems, payers, and plan sponsors.

2 investors

Bend Health is a national healthcare provider delivering mental health care to families and adolescents through an innovative model designed to increase access and reduce costs. The company builds digital and clinical services to help kids and teens develop resilience skills.

2 investors

Bento operates a dental benefits platform that lets employers, associations, and health plans offer self-insured, customizable dental and vision plans with transparent pricing and AI-enabled real-time claim adjudication. It serves employers and groups, plan members, and brokers across the US, providing a connected dental network and concierge support.

2 investors

A Russian insurance and healthcare company that offers tech-enabled insurance products and medical services through a digital platform. The company provides employee health insurance (ДМС), individual insurance policies, and telemedicine services, operating across Russia.

2 investors

BetaGlue develops solutions for the medical device and healthcare sector, supported by a board of directors with expertise in interventional radiology, nuclear medicine, and clinical operations.

2 investors

Betaliq is a clinical-stage pharmaceutical company developing topical eye-drop therapies for glaucoma using a licensed water-free drug delivery platform (EyeSol). Its lead candidate, BTQ1902, is a timolol suspension in development for elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

2 investors

Better Life Partners provides same-day medication-assisted treatment for opioid and alcohol addiction, combining counseling, community support, and medication for people in recovery. It also offers mental health care and responsive primary care for conditions like STIs and pain, with services covered by Medicaid, Medicare, other insurance, or a self-pay option.

2 investors

Better Medicine develops AI-powered tools for medical imaging analysis designed to enhance radiologist workflows and diagnostic accuracy. The company combines expertise in healthcare, radiology, and AI research to create solutions for clinical use.

2 investors

BetterNight provides sleep medicine services including home sleep testing, positive airway pressure (PAP) therapy, oral appliance therapy, and behavioral sleep medicine treatment for patients with sleep disorders. The company serves over 60,000 patients annually in the San Diego metropolitan region and operates through a team of sleep health professionals including polysomnographic technicians, respiratory therapists, cognitive behavioral therapy counselors, and physicians.

2 investors

BetterPlace is a mental health clinic offering integrated diagnostic assessments and evidence-based treatment for conditions including depression, anxiety, bipolar disorder, OCD, and schizophrenia. The company operates in India with a multidisciplinary team of psychiatrists and psychotherapists who provide personalized, multi-modal treatment plans combining therapy and medication.

2 investors

Bevimi is a cognitive health innovation company developing products designed to support brain health, cognitive performance, and longevity through scientifically-formulated supplements and interventions.

2 investors

Beyond Health provides remote patient monitoring, chronic care management, and behavioral health integration services integrated into primary care settings for patients with chronic conditions. The company aims to improve health outcomes and reduce unnecessary hospitalizations through personalized, proactive care delivery.

2 investors

Beyond Spring Pharmaceuticals develops Plinabulin, a brain-penetrant immune modulator that activates dendritic cells through a differentiated tubulin-binding mechanism, intended to enhance antigen presentation and T cell activation for select tumor types. The compound demonstrates clinical benefit in extending overall survival and reducing severe chemotherapy-related neutropenia.

2 investors

2 investors

Biiah provides a measurement and evaluation platform designed for arts and culture organizations to demonstrate the wellbeing impact of their programs. The platform captures participant voice and outcomes data specifically for arts-based interventions including music, theatre, and creative activities.

2 investors

Bioceptive develops women's health medical devices, including a patented FDA-approved Cervical Suction Retractor that replaces the tenaculum for gynecological procedures and an IUD inserter, offering single-use disposable instruments aimed at reducing pain during transcervical procedures. It serves healthcare professionals in the U.S. and developing regions, and is based in New Orleans, Louisiana.

2 investors

BioDigital provides an interactive 3D visualization platform for anatomy, disease, and treatment education that enables educators, clinicians, and patient engagement teams to create and embed customizable health visualizations across digital platforms.

2 investors

BioEclipse Therapeutics is a clinical-stage oncology company developing immuno-oncology therapeutics using a proprietary platform that targets the tumor microenvironment through engineered immune cell therapies. The company's approach combines multiple mechanisms of action to eradicate cancer cells and generate durable immune responses against relapse and recurrence.

2 investors

Biograph operates preventive health clinics that conduct comprehensive health assessments combining imaging, blood biomarkers, and cardiac testing to help individuals optimize their healthspan and lifespan. The service targets individuals seeking proactive, personalized health evaluation in a private clinical setting.

2 investors

BioGrip develops non-invasive neuromuscular sensing technology combined with adaptive AI to decode human intention and enable intuitive control of prosthetics, rehabilitation systems, and robotics. The company targets individuals with mobility impairments and muscular or peripheral nerve damage.

2 investors

BioLattice develops engineered cornea tissue as an alternative to donor cornea for patients with corneal blindness and those waiting for transplants. The company focuses on tissue engineering to address the shortage of donor cornea supply in the global ophthalmology market.

2 investors

BiomeBank develops microbiome-based therapies aimed at restoring the gut microbial ecosystem, with a focus on conditions such as inflammatory bowel disease and Clostridioides difficile infection. The company operates a cGMP manufacturing facility in Adelaide and works with academic and hospital research partners on drug discovery and clinical development.

2 investors